Detalhe da pesquisa
1.
The state of art on the use of patient reported outcomes in migraine.
Curr Opin Neurol
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529698
2.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516125
3.
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
Cephalalgia
; 44(2): 3331024231222923, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307497
4.
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
Cephalalgia
; 44(3): 3331024241234068, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518177
5.
Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study.
Cephalalgia
; 44(2): 3331024241230279, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416486
6.
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
Eur J Neurol
; : e16251, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415282
7.
Migraine treatment: quo vadis? Real-world data study (2015-2022) in Spain.
BMC Neurol
; 24(1): 107, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566063
8.
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.
J Headache Pain
; 25(1): 58, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637736
9.
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
J Headache Pain
; 25(1): 40, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491460
10.
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
J Headache Pain
; 25(1): 21, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347485
11.
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine.
Ann Neurol
; 92(5): 846-859, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054144
12.
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions.
Cephalalgia
; 43(2): 3331024221145916, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759209
13.
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
Cephalalgia
; 43(4): 3331024231159366, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855951
14.
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study.
Cephalalgia
; 43(8): 3331024231177636, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555331
15.
Epidemiology, burden and clinical spectrum of cluster headache: a global update.
Cephalalgia
; 43(9): 3331024231201577, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728577
16.
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
Cephalalgia
; 43(5): 3331024231170807, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125484
17.
Harassment in the headache field: a global web-based cross-sectional survey.
Cephalalgia
; 43(8): 3331024231193099, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652444
18.
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization.
Cephalalgia
; 43(2): 3331024221146317, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759321
19.
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Cephalalgia
; 43(11): 3331024231214987, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37987641
20.
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension.
Cephalalgia
; 43(8): 3331024231197118, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661711